<DOC>
	<DOCNO>NCT02878590</DOCNO>
	<brief_summary>Prospective , non-randomized , open label study</brief_summary>
	<brief_title>Clinical Study BONGO Device Treatment Obstructive Sleep Apnea ( OSA )</brief_title>
	<detailed_description>This study prospective , non-randomized , open label , single-center clinical study BONGO NASAL device treatment obstructive sleep apnea . The study consist two laboratory polysomnographic study one two week home period .</detailed_description>
	<mesh_term>Apnea</mesh_term>
	<mesh_term>Sleep Apnea Syndromes</mesh_term>
	<mesh_term>Sleep Apnea , Obstructive</mesh_term>
	<criteria>• Capacity willingness sign inform consent ≥ 21 year age Diagnosis mild moderate OSA ( AHI ≥ 5 AHI ≤ 30 ) within 12 month screen visit 3 % hypopnea criterion Able tolerate use device day time trial/acclimation Are currently use CPAP prescribe CPAP consider CPAP nonadherent ( per either CPAP data card and/or verbal confirmation diagnosis unwillingness use CPAP ) • Nasal deformity Severe nasal allergy Rhinitis moderate nasal congestion , acute upper respiratory ( include nasal , sinus middle ear ) inflammation infection , perforation ear drum Comorbid sleep disorder Currently hypnotic insomnia ( insomnia month take hypnotic daily basis and/or transient insomnia treat ) Uncontrolled serious illness , include limited : severe breathe disorder include hypercapnic respiratory failure , respiratory muscle weakness , bullous lung disease ( see type emphysema ) , bypass upper airway , pneumothorax , pneumomediastinum , etc . ; severe heart disease ( include heart failure ) ; pathologically low blood pressure . Full Face Mask user Mouth breather Pregnant ( Female subject child bear age ask and/or plan become pregnant study ; acceptable method birth control include birth control pills barrier method )</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>